Press Releases Lavipharm S.A.

Equities

Market Closed - Athens S.E. Other stock markets 07:48:00 15/05/2024 pm IST			5-day change	1st Jan Change
0.956 ^EUR	+6.82%		+11.16%	+20.10%

28/02	Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi.	CI

Lavipharm S A : Annual Analysts Briefing	24/04	PU
Lavipharm S A : ANNOUNCEMENT	11/12	PU
Lavipharm S A : enters into a new asset purchase agreement	11/12	PU
Lavipharm S A : Asset Purchase Agreement for Lavipharm	01/12	PU
Lavipharm S A : FINANCIAL RESULTS FIRST HALF OF 2023	21/23/21	PU
Lavipharm S A : First Half 2023 Financial Results – Strong EBITDA increase	21/23/21	PU
Lavipharm S A : Annual Shareholders’ Meeting	06/23/06	PU
Lavipharm S A : PRESS RELEASE SHAREHOLDERS MEETING	06/23/06	PU
Lavipharm S A : Press Release Extraordinary Shareholders’ Meeting	26/23/26	PU
Lavipharm S A : Results Q1 2023	04/23/04	PU
Lavipharm S A : AMENDMENT OF THE 2023 FINANCIAL CALENDAR	27/23/27	PU
Lavipharm S A : ANNOUNCEMENT	28/23/28	PU
Lavipharm S A : Announcement 1668/2023	15/23/15	PU
Lavipharm S A : further enhances its product portfolio in Urology	01/23/01	PU
Lavipharm S A : share re-enters ATHEX Main Market	22/22/22	PU
Lavipharm S A : Tikun Europe and Lavipharm enter into a strategic alliance	15/22/15	PU
Lavipharm : Annual Shareholders’ Meeting	30/22/30	PU
Lavipharm S A : HEAD OF INVESTORS' RELATIONS	18/22/18	PU
Lavipharm S A : Announcement 9482/2021 (no English translation available)	30/21/30	PU
Lavipharm S A : Announcement 9142/2021 (no English translation available)	22/21/22	PU

No results for this search